Trexquant Investment’s Day One Biopharmaceuticals DAWN Stock Holding History

Trexquant Investment’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-266,580	Closed	-$1.88M	–	1646
2025 Q3	$1.88M	Buy	266,580 +151,153	+131%	+$1.04M	0.02%	928
2025 Q2	$750K	Sell	115,427 -89,355	-44%	-$615K	0.01%	1170
2025 Q1	$1.62M	Buy	204,782 +116,810	+133%	+$1.26M	0.02%	932
2024 Q4	$1.11M	Buy	+87,972	New	+$1.22M	0.01%	1067
2023 Q4	–	Sell	-97,868	Closed	-$1.2M	–	1501
2023 Q3	$1.2M	Buy	+97,868	New	+$1.28M	0.03%	678
2023 Q2	–	Sell	-52,335	Closed	-$700K	–	1505
2023 Q1	$700K	Buy	+52,335	New	+$1.02M	0.02%	869

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's DAWN Position: Q4 2025 in Review

Trexquant Investment sold out of Day One Biopharmaceuticals (DAWN) in Q4 2025, closing a stake of 266,580 shares — an estimated $1.88M sold.

Trexquant Investment first reported a position in DAWN in Q1 2023 and held it in 6 quarters. The position peaked at $1.88M in Q3 2025. 183 funds tracked by Wall St. Rank hold DAWN as of Q4 2025.

Trexquant Investment reported no remaining Day One Biopharmaceuticals position as of Q4 2025 after selling out during the quarter.
Trexquant Investment sold 266,580 Day One Biopharmaceuticals shares in Q4 2025, an estimated $1.88M.
Trexquant Investment first reported a position in Day One Biopharmaceuticals in Q1 2023 and held it in 6 quarters.
Trexquant Investment's Day One Biopharmaceuticals position peaked at $1.88M in Q3 2025.
183 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2025.

Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.